These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1106 related items for PubMed ID: 23314734
21. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children. Trame MN, Bergstrand M, Karlsson MO, Boos J, Hempel G. Clin Cancer Res; 2011 Nov 01; 17(21):6867-77. PubMed ID: 21918171 [Abstract] [Full Text] [Related]
22. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study. Frost BM, Eksborg S, Björk O, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Lönnerholm G. Med Pediatr Oncol; 2002 May 01; 38(5):329-37. PubMed ID: 11979457 [Abstract] [Full Text] [Related]
23. Toxicokinetics of the active doxorubicin metabolite, doxorubicinol, in sulphur-crested cockatoos (Cacatua galerita). Gilbert CM, Filippich LJ, McGeary RP, Charles BG. Res Vet Sci; 2007 Aug 01; 83(1):123-9. PubMed ID: 17197005 [Abstract] [Full Text] [Related]
24. Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass. Barpe DR, Rosa DD, Froehlich PE. Eur J Pharm Sci; 2010 Nov 20; 41(3-4):458-63. PubMed ID: 20688160 [Abstract] [Full Text] [Related]
25. Population pharmacokinetic analysis of 17-(allylamino)-17-demethoxygeldanamycin (17AAG) in adult patients with advanced malignancies. Chen X, Bies RR, Ramanathan RK, Zuhowski EG, Trump DL, Egorin MJ. Cancer Chemother Pharmacol; 2005 Mar 20; 55(3):237-43. PubMed ID: 15503027 [Abstract] [Full Text] [Related]
26. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients. Rezai K, Urien S, Isambert N, Roche H, Dieras V, Berille J, Bonneterre J, Brain E, Lokiec F. Cancer Chemother Pharmacol; 2011 Dec 20; 68(6):1529-36. PubMed ID: 21519841 [Abstract] [Full Text] [Related]
27. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis. Potts AL, Anderson BJ, Warman GR, Lerman J, Diaz SM, Vilo S. Paediatr Anaesth; 2009 Nov 20; 19(11):1119-29. PubMed ID: 19708909 [Abstract] [Full Text] [Related]
28. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%. Knibbe CA, Zuideveld KP, DeJongh J, Kuks PF, Aarts LP, Danhof M. Clin Pharmacol Ther; 2002 Dec 20; 72(6):670-84. PubMed ID: 12496748 [Abstract] [Full Text] [Related]
29. Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol. Hempel G, Relling MV, de Rossi G, Stary J, De Lorenzo P, Valsecchi MG, Barisone E, Boos J, Pieters R. Pediatr Blood Cancer; 2010 Mar 20; 54(3):355-60. PubMed ID: 19731319 [Abstract] [Full Text] [Related]
30. Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients. Sandström M, Lindman H, Nygren P, Johansson M, Bergh J, Karlsson MO. Cancer Chemother Pharmacol; 2006 Aug 20; 58(2):143-56. PubMed ID: 16465545 [Abstract] [Full Text] [Related]
31. Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients. Hahn G, Sorge I, Gruhn B, Glutig K, Hirsch W, Bhargava R, Furtner J, Born M, Schröder C, Ahlström H, Kaiser S, Moritz JD, Kunze CW, Shroff M, Stokland E, Trnkova ZJ, Schultze-Mosgau M, Reif S, Bacher-Stier C, Mentzel HJ. Invest Radiol; 2009 Dec 20; 44(12):776-83. PubMed ID: 19858730 [Abstract] [Full Text] [Related]
32. Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy. Rudek MA, Sparreboom A, Garrett-Mayer ES, Armstrong DK, Wolff AC, Verweij J, Baker SD. Eur J Cancer; 2004 May 20; 40(8):1170-8. PubMed ID: 15110880 [Abstract] [Full Text] [Related]
33. Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study. Mross K, Niemann B, Massing U, Drevs J, Unger C, Bhamra R, Swenson CE. Cancer Chemother Pharmacol; 2004 Dec 20; 54(6):514-24. PubMed ID: 15322827 [Abstract] [Full Text] [Related]
34. Population pharmacokinetics of propofol: a multicenter study. Schüttler J, Ihmsen H. Anesthesiology; 2000 Mar 20; 92(3):727-38. PubMed ID: 10719952 [Abstract] [Full Text] [Related]
35. Population pharmacokinetics of high-dose carboplatin in children and adults. Lindauer A, Eickhoff C, Kloft C, Jaehde U. Ther Drug Monit; 2010 Apr 20; 32(2):159-68. PubMed ID: 20110851 [Abstract] [Full Text] [Related]
37. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K. Cancer Chemother Pharmacol; 2003 Jun 20; 51(6):465-73. PubMed ID: 12698270 [Abstract] [Full Text] [Related]
38. Population pharmacokinetics of modafinil and its acid and sulfone metabolites in Chinese males. Seng KY, Fan L, Lee HS, Yong WP, Goh BC, Lee LS. Ther Drug Monit; 2011 Dec 20; 33(6):719-29. PubMed ID: 22105589 [Abstract] [Full Text] [Related]
39. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Aumente D, Buelga DS, Lukas JC, Gomez P, Torres A, García MJ. Clin Pharmacokinet; 2006 Dec 20; 45(12):1227-38. PubMed ID: 17112298 [Abstract] [Full Text] [Related]
40. Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients. Nath CE, Shaw PJ, Montgomery K, Earl JW. Br J Clin Pharmacol; 2007 Aug 20; 64(2):151-64. PubMed ID: 17324241 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]